An anti-coronavirus drug developed by Defence Research and Development Organisation (DRDO) will be launched today, with Union Defence Minister Rajnath Singh distributing around 10,000 doses to some hospitals in the national capital.
The drug, called 2-deoxy-D-glucose or 2-DG, was developed by a DRDO lab in collaboration with the Hyderabad-based pharma giant, Dr Reddy’s Laboratories. Drugs Controller General of India (DCGI), the country’s top drug regulator, has approved the medicine for emergency use.
Meanwhile, UNICEF on Monday said, Countries belonging to the G7 and the European Union can afford to donate more than 150 million vaccines to countries in need without compromising their own goals, AFP reported.
Here are the Live Updates on India Coronavirus (Covid-19 Cases) Cases:
The Centre today clarified that bookings already done online or onsite for the second dose of Covishield vaccine won’t be cancelled despite the gap after the first recently being extended by the government. While beneficiaries are advised to reschedule the appointments for their next round to some date beyond the 84-day gap now required, they will not be turned back if they choose to go by the slots already allotted to them. Read Here
Meghalaya on Sunday reported 569 new COVID-19 cases, which took the tally in the state to
23,332, a health department official said. The death toll count to 320 as 19 more people died due
to the disease, PTI reported.
Uttar Pradesh Chief Minister Yogi Adityanath on Sunday announced that nine medical oxygen plants have been approved for Ghaziabad and three for adjoining Gautam Buddh Nagar district.
The chief minister said this while on a one-day tour of Gautam Buddh Nagar, Ghaziabad and Meerut to review the pandemic situation in these three districts of western UP, PTI reported.